Publication | Closed Access

A natural product-derived nanozyme regulator induced chemo-ferroptosis dual therapy in remodeling of the tumor immune microenvironment of hepatocellular carcinoma

NanomedicineTumor BiologyTumor Immune MicroenvironmentHepatocellular CarcinomaChemo-ferroptosis Dual TherapyImmunologyTumor ImmunityTumor TargetingLiver CancerMedicineRadiation OncologyTumor MicroenvironmentCancer Research